Vitrolife AB（publ）报告第二季度业绩

2025-07-17 20:28

Vitrolife AB (publ) press release (OTCPK:VTRLY): Q2 Net income was SEK 100 (143) million, resulting in earnings per share of SEK 0.74 (1.06).
Gross margin decreased to 58.0% (59.9) also negatively impacted by currency.
Earnings before depreciation and amortisation (EBITDA) decreased to SEK 243 (327) million, resulting in an EBITDA margin of 27.8% (34.7), significantly impacted by negative currency effect.
Operating cash flow amounted to SEK 151 million (236).

More on Vitrolife AB (publ)